Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio

Today at a news conference, it was announced that German-based company Cytocentrics Bioscience (Cytocentrics) is relocating its corporate headquarters and operations to San Antonio’s District 9. City Council voted to approve an up to $1 million grant over five years, as part of an agreement with the company in which it will create 300 high-wage jobs with an average salary of $70,000 and invest $15 million, and enter into a research development partnership with the Center for Innovative Drug Discovery (CIDD), a joint venture between the University of Texas at San Antonio (UTSA) and UT Health Science Center at San Antonio, as well as another partnership for workforce development with Alamo Colleges.

Cytocentrics manufacturers and analyzes data for a medical device called a CytoPatch Machine that automates a medical “patch clamp” technique. This technique evaluates environmental and pharmaceutical interactions with human cells. This technique is an example of the convergence of robotics, microbiology and bioscience.

The research partnership has significant potential impact for drug discovery research across multiple therapeutic disciplines, and will benefit several different departments at UTSA and UT Health Science Center. It’s also expected that this partnership will complement UTSA’s drive to obtaining Tier-1 status.

Mayor Taylor particularly commended Cytocentrics for entering into these partnerships with the institutions of higher learning.

“Both of these partnerships are great steps towards further preparing San Antonio’s workforce in the biosciences industry,” said Mayor Taylor during the news conference. She also stated that this project is “indicative of [the City’s] efforts to focus on the biomedical industry, which currently employs one in six San Antonians and has over an estimated $30 billion in economic impact.”

Mayor Ivy Taylor, District 9 Councilman Joseph Krier and City Manager Sheryl Sculley thanked the company for choosing to relocate its headquarters and manufacturing operations to San Antonio.

Councilman Krier said: “as co-chair of the San Antonio Medical Foundation’s Strategic planning task force, this announcement is dramatic support of our call for out-of-the-box cooperation and collaboration.”

Dr. Jim Garvin, CEO of Cytocentrics also took the stage thanking the City of San Antonio for the grant.

Garvin added that “this grant continues to tell the world about the unique impact our company is having on the world of medical research and what that impact can mean for improving all our lives. As well as telling the scientific community that San Antonio is a dynamic, vibrant community and a great place to come and be a part of."

All of the institutes of higher learning shared their gratitude to the company for their partnership and further explained why these are crucial for research and the biomedical ecosystem not only in San Antonio, but all of South Texas.

"In a time when research funding is scarce and collaboration is essential, we are happy to welcome Cytocentrics Bioscience to San Antonio and are grateful for their generosity," said William L. Henrich, M.D., President of the UT Health Science Center. "We are proud to partner with our sister institution, UTSA, on the Center for Innovative Drug Discovery and are pleased to house two CytoPatch Machines on our Health Science Center campus, where other institutions in South Texas may utilize them for research as well.”

Dr. Henrich added that “the technology of the CytoPatch is very sophisticated and will provide opportunities to expand our research and garner additional grant funding to foster discovery."

UTSA’s Vice President for Research Dr. Mauli Agrawal also shared Dr. Henrich’s sentiment on the company’s collaboration.

“San Antonio is known for its collaborative spirit. Cytocentrics’ relocation to San Antonio serves as an example of how the private sector, academia, and the City can partner together to enable progress, drive innovation, and ultimately create more jobs,” said Dr. Agrawal.

“This opportunity for the Alamo Colleges to provide training that will train local workers for high-paying, high tech jobs is further recognition of our status as the primary provider of innovative, successful job training programs tailored to the needs of local employers," said Dr. Federico Zaragoza, Alamo Colleges' Vice Chancellor for Economic and Workforce Development.

City Manager Sheryl Sculley closed the news conference. She gave a breakdown of what type of jobs would come out of the project.

“The job breakdown for these positions include approximately 40 percent professional positions that will require post-graduate level education and about 53 percent that will need some sort of certified training through the Alamo Colleges, with the rest composed of executive and clerical positions,” said Sculley.

About Cytocentrics

Cytocentrics, Inc. is a company that focuses on developing technology that increases our understanding of how human cells respond to various kinds of drugs and drug therapy. Cells have membranes, these membranes have pores, called ion channels – Cytocentrics technologies increase science and medicine’s understanding about those ion channels with an outcome that makes drugs safer and more effective. Additionally, the company is continuing to push development of cellular biology. The Cytocentrics technology is a unique blend of nano chip development, robotics, biochemistry, and physics.

City on the Rise: San Antonio

San Antonio is a city on the rise for the new face of America—a diverse, progressive and globally competitive city with a solid vision for national and international economic development. The City of San Antonio maintains a strong financial position with a “AAA” general obligation bond rating from all three major rating agencies. In 2014, Forbes labeled San Antonio the “Best City in the Southwest” for adults ages 18-34 for its dynamic economy, employment opportunities and affordable living. As the seventh-largest city in the United States, San Antonio is experiencing solid economic growth in 21st century industries such as bioscience, aerospace, cybersecurity and healthcare, which contribute billions to the local economy. San Antonio has also positioned itself at the forefront of the New Energy Economy in the United States, committed to investing and creating employment opportunities in green industries. San Antonio continues to experience the addition of missions at its several military commands, further fostering a significant relationship spanning more than 200 years. Nearly 30 million visitors come to San Antonio every year, generating more than $12 billion annually and making the travel industry a vital asset to the city’s economic health.

Source: https://www.sanantonio.gov/

June 11th 2015 back

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more